Navigation Links
Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
Date:1/14/2008

an Orphan Medicinal Product in the EU for the treatment of MDS, which, if approved, entitles the drug to ten years of market exclusivity for the approved indication. Vidaza has also been designated as an Orphan Medicinal Product in the EU for the treatment of acute myeloid leukemia (AML).

The application is based upon clinical data which includes the results from the Company's Phase 3 multi-center, international, randomized study of Vidaza(R) (azacitidine for injection) in the treatment of patients with higher-risk MDS. The primary objective of this Phase 3 trial was to demonstrate superiority in overall survival of Vidaza versus CCR. The study included 358 patients at sites in the U.S., Europe, and Australia. At baseline, approximately 90 percent of patients were considered to have higher- risk MDS, based on subsequent independent review of FAB subtypes or IPSS classification. Patients were assigned to treatment with Vidaza (N=179; 75 mg/m2/day SC for seven consecutive days every 28 days) or CCR. Patients assigned to CCR could receive either BSC alone (N=105), low-dose cytarabine (LDAC; N=49), or standard chemotherapy (Std Chemo; N=25). The median number of cycles for Vidaza was nine; the median number of cycles for the CCR arm was as follows: BSC seven cycles, LDAC 4.5 cycles and Std Chemo one cycle.

With a median follow-up of 21.1 months, Vidaza demonstrated a statistically significant overall survival advantage over CCR (24.4 months vs. 15 months; stratified log rank p=0.0001).The hazard ratio describing this treatment effect was 0.58 (95 percent confidence interval of 0.43 to 0.77). At two years, Vidaza demonstrated a two-fold advantage in overall survival over CCR (51 percent vs. 26 percent; log rank p<0.0001). Among patients with poor cytogenetic profiles (as defined by IPSS, 28 percent of enrolled patients), median survival was 17.2 months in the Vidaza arm, compared to six months in the CCR arm (log rank p=0.01). Forty-five percent of transfu
'/>"/>

SOURCE Pharmion Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
2. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
3. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
4. Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
5. Pharmion and MethylGene Initiate Phase One Combination Clinical Trial with MGCD0103 and Taxotere(R) in Patients with Solid Tumors
6. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
7. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
8. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
11. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. The delivery of drugs to ... the treatment of neurological disorders. Drugs may be ... (e.g., by intravenous injection) for targeted action in ...
(Date:6/2/2015)... Canadian Society for Vascular Surgery (CSVS) today released ... that are commonly ordered but not always necessary ... Canada.  The list identifies five (5) targeted, evidence-based ... physicians about what care is really necessary. ... identified the following five (5) recommendations: ...
(Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Archiving and Communication Systems (PACS) - Global Strategic Business Report" ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... and forecasts are provided for the period 2014 through 2020. ...
Breaking Medicine Technology:Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
(Date:6/2/2015)... Los Angeles, CA (PRWEB) June 02, 2015 ... "100K Factory" system was released to public yesterday, ... around the Internet. HonestyFirstReviews.com's senior product reviewer Tiffany ... posting a detailed review of the course on ... of training courses available for Internet marketers looking ...
(Date:6/2/2015)... On March 19th, 2015, LiveToBeSober.org held an ... of Legends at Detroit’s Ford Field. Hosted by former ... the goal of the conference was to raise awareness ... the benefits of effective professional rehabilitation programs. It also ... that are available to them in regards to the ...
(Date:6/2/2015)... The Down Syndrome Association of Wisconsin (DSAW) ... show Glee as the keynote speaker for its June ... WI. The event aims to raise funds to support ... Walworth counties. , "We couldn't be ... important event," says Dawn Nuoffer, DSAW Executive Director. "She's ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The Horizon ... announced today that its Walking and Wellness Challenge, held ... by Acer, has raised another $3,000 for the Boys ... undertook the challenge, recording 32,000 steps on her fitbit ... Seaview Hotel & Golf Club in Galloway Township. ...
(Date:6/2/2015)... June 02, 2015 “ Radaris ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... data they need on a person. , According to Psychology ... even goes on to explain that curiosity is a part ...
Breaking Medicine News(10 mins):Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2
... reveal people with GERD, gastro-esophageal reflux disease, and ... without these conditions to report excessive daytime sleepiness, ... State University selected more than 1,550 adults, who ... to participate in the study. After a physical ...
... survival time in patients with non-small cell lung cancer. ... often measured only in months, for the disease is ... to the chest wall. In a new approach, doctors ... therapy (PDT) alongside surgery in patients with this form ...
... by researchers that children who light their parents' cigarette or ... In addition, asking children to bring the cigarettes,// buy them ... are all behaviors that encourage children to smoke. ,Rafael ... a parent asks his child to hold the match to ...
... coughs are harmless, while others merit medical attention. A cough ... part and parcel of a cold or flu and, aside ... little you can do.// Other coughs, however, may signify a ... Mayo Clinic point out the situations where a cough needs ...
... oppressive stress have measurable anomalies in their immune system ... believed that stress may impair health, although the underlying// ... in the US reveal that exposure to chronic stress ... an inflammatory response is set up - in response ...
... that second twins born at term are at a higher ... than first twins. However, planned caesarean section may prevent such ... born in Scotland between 1995 and 1998. They found significantly ... second twins born at term. No deaths were recorded among ...
Cached Medicine News:
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Coronary angiographic catheter...
The entirely open modular system is especially suitable for stereotactic microsurgical procedures....
Used to negotiate tortuous vessels....
Medicine Products: